{"id":5191,"date":"2007-04-05T00:00:00","date_gmt":"2007-04-05T00:00:00","guid":{"rendered":"http:\/\/wordpress.dev\/?p=5191"},"modified":"2007-04-05T00:00:00","modified_gmt":"2007-04-05T00:00:00","slug":"fda-sleep-drugs-label-change","status":"publish","type":"post","link":"https:\/\/www.achooallergy.com\/blog\/fda-sleep-drugs-label-change\/","title":{"rendered":"FDA Requests Label Changes for Sleep Disorder Drugs"},"content":{"rendered":"

The Doctor's Guide<\/a> reports that FDA has requested that all manufacturers of sedative-hypnotic drug products (a class of drugs used to induce and\/or maintain sleep) strengthen their product labeling to include stronger language concerning potential risks like dangerous behaviors, allergic reactions, and even anaphylaxis (a severe, life-threatening allergic reaction).<\/p>\n

One potential risk is sleep-driving. Yes, sleep-driving<\/i>, defined as driving while not fully awake after ingestion of a sedative-hypnotic product, with no memory of the event.<\/p>\n

Drugs affected by the label change include: Ambien, Busitol Sodium, Carbrital, Dalmane, Doral, Halcion, Lunesta, Placidyl, Prosom, Restoril, Rozerem, Seconal, and Sonata.<\/p>\n

See The Importance of Healthy Sleep<\/a> for tips on how to sleep well without potentially dangerous drugs.<\/p>\n","protected":false},"excerpt":{"rendered":"

The Doctor's Guide reports that FDA has requested that all manufacturers of sedative-hypnotic drug products (a class of drugs used to induce and\/or maintain sleep) strengthen their product labeling to include stronger language concerning potential risks like dangerous behaviors, allergic… <\/p>\n